We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
Cap. Flow
-$2.3B
Cap. Flow %
-2.9%
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$331M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$327M
3
NVO
Novo Nordisk
NVO
+$319M
4
ALSN icon
Allison Transmission
ALSN
+$195M
5
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
+$50M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$853M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$294M
3
NVDA icon
NVIDIA
NVDA
+$266M
4
NFLX icon
Netflix
NFLX
+$190M
5
META icon
Meta Platforms (Facebook)
META
+$175M

Sector Composition

Rank Sector Weight
1 Technology 27.48%
2 Consumer Discretionary 18.83%
3 Communication Services 18.1%
4 Healthcare 11.79%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEN icon
201
Penumbra
PEN
$12.8B
$29M 0.04%
122,280
+9,897
+9% +$2.25M
POST icon
202
Post Holdings
POST
$3.57B
$28.7M 0.04%
250,436
+30,851
+14% +$3.52M
JNK icon
203
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.31B
$28.2M 0.04%
295,498
+74,152
+34% +$7.16M
TYL icon
204
Tyler Technologies
TYL
$12.8B
$28M 0.04%
48,627
-1,561
-3% -$943K
KFY icon
205
Korn Ferry
KFY
$4.28B
$28M 0.04%
415,488
+8,058
+2% +$586K
NOMD icon
206
Nomad Foods
NOMD
$1.68B
$28M 0.04%
1,669,097
+250,600
+18% +$4.38M
PRVA icon
207
Privia Health
PRVA
$2.87B
$27.7M 0.04%
1,418,234
+503,002
+55% +$9.97M
UTHR icon
208
United Therapeutics
UTHR
$23.1B
$27.7M 0.03%
78,435
-70,046
-47% -$25.7M
XENE icon
209
Xenon Pharmaceuticals
XENE
$6.12B
$26.9M 0.03%
687,145
-20,077
-3% -$830K
VRDN icon
210
Viridian Therapeutics
VRDN
$2.67B
$26.8M 0.03%
+1,400,381
New +$30.4M
VST icon
211
Vistra
VST
$47.4B
$25.9M 0.03%
187,559
-118,194
-39% -$16.4M
LNTH icon
212
Lantheus
LNTH
$6.59B
$25.5M 0.03%
284,766
+4,600
+2% +$448K
EXLS icon
213
EXL Service
EXLS
$5.29B
$25.4M 0.03%
572,514
+121,693
+27% +$5.26M
XNCR icon
214
Xencor
XNCR
$1.55B
$25.1M 0.03%
1,092,346
+192,080
+21% +$4.41M
BBWI icon
215
Bath & Body Works
BBWI
$4.1B
$24.9M 0.03%
641,331
+328,942
+105% +$11M
MTDR icon
216
Matador Resources
MTDR
$6.09B
$24.8M 0.03%
441,683
-13,979
-3% -$770K
NVMI
217
Nova
NVMI
$12.5B
$24.7M 0.03%
125,354
-3,914
-3% -$752K
ASND icon
218
Ascendis Pharma A/S
ASND
$16.8B
$24.6M 0.03%
178,899
-5,724
-3% -$753K
AXSM icon
219
Axsome Therapeutics
AXSM
$10.9B
$24.5M 0.03%
290,111
-8,475
-3% -$779K
OPCH icon
220
Option Care Health
OPCH
$3.56B
$24.4M 0.03%
1,050,549
+28,790
+3% +$728K
SKY icon
221
Champion Homes
SKY
$5.14B
$24.3M 0.03%
275,991
+97,482
+55% +$9.42M
AL
222
DELISTED
Air Lease Corp
AL
$24M 0.03%
498,833
+95,006
+24% +$4.48M
WTFC icon
223
Wintrust Financial
WTFC
$10.7B
$23.9M 0.03%
191,962
– –
MIRM icon
224
Mirum Pharmaceuticals
MIRM
$6.14B
$23.9M 0.03%
578,024
+78,708
+16% +$3.28M
LFUS icon
225
Littelfuse
LFUS
$11.6B
$23.8M 0.03%
101,034
+1,898
+2% +$473K
7 8
9
10 11

Similar funds

CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Loomis, Sayles & Company's Q4 2024 Portfolio in Review

As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
  • Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
  • Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
  • Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
  • Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
  • Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
  • Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.